Bo Kruse - 22 Jul 2021 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	YMAB	Common Stock	Sale	$138,000	-4,000	-1.7%	$34.50^*	237,077	22 Jul 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2021.